Mankind Pharma completed a landmark strategic acquisition of 100 percent stake in Bharat Serums and Vaccines Limited (BSV) for a massive purchase consideration of approximately ₹13,768 Crores. This milestone transaction positioned Mankind as a formidable market leader in the Indian women's health and fertility drug sectors, while providing crucial access to high entry barrier critical care portfolios, complex biological research platforms, and advanced immunoglobulins.